Datavault AI Issues Formal Response to Wolfpack Research’s Malicious Short Report; Company Affirms the Strength of Its Intellectual Property, Leadership, and Strategic Direction
TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two u......
The acquisition represents Copenhagen Infrastructure Partner’s entry into the UK bioenergy market and is the fourth investment in CIP’s Advanced Bioenergy Fund (CI ABF I).
